We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
- Authors
Soini, Tuuli; Hurskainen, Ritva; Grénman, Seija; Mäenpää, Johanna; Paavonen, Jorma; Pukkala, Eero
- Abstract
Background: Levonorgestrel-releasing intrauterine system (LNG-IUS) is used for contraception and heavy menstrual bleeding. A long-term hormone therapy can modify the risk of gynecologic cancers. Little is known about the impact of LNG-IUS use on the risk for invasive and borderline ovarian tumor subtypes or for primary fallopian tube carcinoma. We examined the associations of LNG-IUS use with these tumors. Material and methods: We identified from the national Medical Reimbursement Registry of Finland the women aged 30–49 years who had used LNG-IUS for menorrhagia in 1994–2007, and from the Finnish Cancer Registry ovarian cancers and primary fallopian tube carcinomas diagnosed before the age of 55 and by the end of 2013. Results: A total of 77 invasive ovarian cancers and seven primary fallopian tube carcinoma cases were diagnosed in a cohort of 93 843 LNG-IUS users during the follow-up of 1 083 126 women-years. The LNG-IUS users had decreased risk for both invasive ovarian cancer [standardized incidence ratio (SIR) 0.59, 95% confidence interval (CI) 0.47–0.73] and for borderline ovarian tumors (SIR 0.76, 95% CI 0.57–0.99) as compared to the background population. The risk of primary fallopian tube carcinoma was not increased (SIR 1.22, 95% CI 0.49–2.50). Decreased risks for mucinous (SIR 0.49, 95% CI 0.24–0.87), endometrioid (SIR 0.55, 95% CI 0.28–0.98), and serous ovarian carcinomas (SIR 0.75, 95% CI 0.55–0.99) were seen in LNG-IUS users. Conclusions: LNG-IUS use associated with decreased risk for both invasive and borderline ovarian tumors. The incidence of primary fallopian tube carcinoma did not significantly differ between LNG-IUS users and the background population.
- Publication
Acta Oncologica, 2016, Vol 55, Issue 11, p1281
- ISSN
0284-186X
- Publication type
Article
- DOI
10.1080/0284186X.2016.1175660